Nantong Jinghua Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is FLUCYTOSINE, with a corresponding US DMF Number 25094.
Remarkably, this DMF maintains an Active status since its submission on July 14, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 05, 2015, and payment made on February 04, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II